A Study To Look At Safety And Blood Concentrations After Multiple Doses Of PF-03382792 In Healthy Elderly Individuals

NCT01089738 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: PF-03382792 0.5mg
DRUG: PF-03382792 1.5 mg
DRUG: PF-03382792 5 mg
DRUG: PF-03382792 15 mg

Sponsor

Pfizer